The effect of diet on simvastatin and losartan enhancement of endothelial function

被引:12
作者
Bayorh, Mohamed A.
Layas, Mohammed F.
Mann, Garret
Feuerstein, Giora Z.
Eatman, Danita
机构
[1] Morehouse Sch Med, Dept Pharmacol & Toxicol, Atlanta, GA 30310 USA
[2] Merck & Co Inc, New Point, NJ USA
关键词
SHR; simvastatin; losartan; cholesterol; prostaglandins; nitric oxide;
D O I
10.1080/10641960701500463
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Patients with hypertension take antihypertensive agents and cholesterol-lowering drugs; however, few studies describe the effects of the interaction of anti-hypertensive agents with statins. Therefore, the purpose of this study was to characterize the effects of losartan, simvastatin, and their combination on the progression of hypertension in the spontaneously hypertensive rats (SHRs). Also, we determined whether diet influenced the drug responses. Rats were fed three different diets-low-salt (LS), high-salt (HS), and lipid-rich (LR)-and treated with either no drug (control), losartan (LOS, 10 mg/kg/day), shnvastatin (SIM, 2 mg/kg/day) or LOS combined with SIM for four weeks. After four weeks on the diets, systolic blood pressure rose in all groups and remained elevated. Treatment with LOS alone or in combination with SIM reduced BP in the rats fed the LS and HS diet, respectively. Furthermore, LOS alone increased NO in the LS and LR groups; however, LOS combined with SIM completely abolished this rise in NO in LS group. Plasma PGI(2) and TXA(2) levels were increased in the presence of SIM alone; however LOS combined with SIM completely blocked SIM-induced increases in PGI(2) and TXA(2). Kidney levels of angiotensin II were higher in the LS group and significantly increased in the HS group following treatment with LOS alone. However, kidney aldosterone levels were significantly reduced in the presence of LOS in the HS group. Total cholesterol, LDL cholesterol, and triglycerides were significantly higher in the LR group. Together, these data suggest a contribution of endogenous NO and PGs in the antihypertensive effect of LOS and SIM that may be affected by the type of diet.
引用
收藏
页码:311 / 325
页数:15
相关论文
共 32 条
[21]   Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month [J].
ODriscoll, G ;
Green, D ;
Taylor, RR .
CIRCULATION, 1997, 95 (05) :1126-1131
[22]   Regulation of vascular tone from spontaneously hypertensive rats by the HMG-CoA reductase inhibitor, simvastatin [J].
Pérez-Guerrero, C ;
Márquez-Martín, A ;
Herrera, MD ;
Marhuenda, E ;
de Sotomayor, MA .
PHARMACOLOGY, 2005, 74 (04) :209-215
[23]  
POMERANTZ KB, 1985, J LIPID RES, V26, P1269
[24]   Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy [J].
Rizzoni, D ;
Muiesan, ML ;
Porteri, E ;
Castellano, M ;
Zulli, R ;
Bettoni, G ;
Salvetti, M ;
Monteduro, C ;
AgabitiRosei, E .
JOURNAL OF HYPERTENSION, 1997, 15 (02) :197-204
[25]   Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic - Role of nitric oxide [J].
Schnackenberg, CG ;
Welch, WJ ;
Wilcox, CS .
HYPERTENSION, 1998, 32 (01) :59-64
[26]   Contribution of vascular NAD(P)H oxidase to endothelial dysfunction in heart failure and the therapeutic effects of HMG-CoA reductase inhibitor [J].
Takayama, T ;
Wada, A ;
Tsutamoto, T ;
Ohnishi, M ;
Fujii, M ;
Isono, T ;
Horie, M .
CIRCULATION JOURNAL, 2004, 68 (11) :1067-1075
[27]   Angiotensin II and oxidative stress in Dahl salt-sensitive rat with heart failure [J].
Tojo, A ;
Onozato, ML ;
Kobayashi, N ;
Goto, A ;
Matsuoka, H ;
Fujita, T .
HYPERTENSION, 2002, 40 (06) :834-839
[28]   Preservation of NO production by statins in the treatment of heart failure [J].
Trochu, JN ;
Mital, S ;
Zhang, XP ;
Xu, XB ;
Ochoa, M ;
Liao, JK ;
Recchia, FA ;
Hintze, TH .
CARDIOVASCULAR RESEARCH, 2003, 60 (02) :250-258
[29]   HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species [J].
Wassmann, S ;
Laufs, U ;
Bäumer, AT ;
Müller, K ;
Ahlbory, K ;
Linz, W ;
Itter, G ;
Rösen, R ;
Böhm, M ;
Nickenig, G .
HYPERTENSION, 2001, 37 (06) :1450-1457
[30]   Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury [J].
Yokota, N ;
O'Donnell, M ;
Daniels, F ;
Burne-Taney, M ;
Keane, W ;
Kasiske, B ;
Rabb, H .
AMERICAN JOURNAL OF NEPHROLOGY, 2003, 23 (01) :13-17